Years of potential life lost and productivity costs due to premature cancer-related mortality in Iran

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 5, 2015, Pages 1845-1850

  Khorasani, Soheila ^a   Rezaei, Satar ^b   Rashidian, Hamideh ^c   Daroudi, Rajabali ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer; Economic burden; Iran; Productivity costs; Years of potential life lost

Indexed keywords

COST OF ILLNESS; ECONOMICS; FEMALE; HUMAN; IRAN; LIFE EXPECTANCY; MALE; MORTALITY; NEOPLASM;

COST OF ILLNESS; FEMALE; HUMANS; IRAN; LIFE EXPECTANCY; MALE; NEOPLASMS;

EID: 84928578905     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.5.1845     Document Type: Article

References (34)

1. Abachizadeh K, Mohagheghi M-A, Mosavi-Jarrahi A (2011). Setting research priorities to reduce burden of cancer in Iran: an institutional experience. Asian Pac J Cancer Prev, 12, 2365-70.
2. Akbarzadeh Ba, Esmaeili M, Kimiafar K (2008). Medical information management and assessment of direct costs of treatment of lung cancer. Health Information Management, 5, 151-8 (in Persian).
3. Bazyar M, Pourreza A, Harirchi I, et al (2010). Medical and non-medical direct costs of cancers in patients hospitalized in Imam Khomeini Cancer Institution-2010. Hospital, 11, 39-50 (in Persian).
4. Bradley CJ, Yabroff KR, Dahman B, et al (2008). Productivity costs of cancer mortality in the United States: 2000-2020. J Natl Cancer Inst, 100, 1763-70.
5. Burnet N, Jefferies S, Benson R, et al (2005). Years of life lost (YLL) from cancer is an important measure of population burden-and should be considered when allocating research funds. Br J Cancer, 92, 241-5.
6. D'Souza ND, Murthy NS, Aras RY (2013). Projection of cancer incident cases for India -till 2026. Asian Pac J Cancer Prev, 14, 4379-86.
7. Davari M, Yazdanpanah F, Aslani A, et al (2013). The direct medical costs of breast cancer in Iran: analyzing the patient's level data from a cancer specific hospital in Isfahan. Int J Prev Med, 4, 748.
8. Ekwueme DU, Chesson HW, Zhang KB, et al (2008). Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003. Cancer, 113, 2936-45.
9. Ekwueme DU, Guy Jr GP, Li C, et al (2011). The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006. J Am Acad Dermatol, 65, 133-43
10. Ferlay J, Soerjomataram I, Ervik M, et al (2012). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 10/10/2014. [Online].
11. Gardner JW, Sanborn JS (1990). Years of potential life lost (YPLL)-what does it measure? Epidemiol, 1, 322-9.
12. Hanly P, Pearce A, Sharp L (2014). The cost of premature cancer-related mortality: a review and assessment of the evidence. Expert review of pharmacoeconomics and outcomes research, 1-23.
13. Hanly P, Soerjomataram I, Sharp L (2015). Measuring the societal burden of cancer: The cost of lost productivity due to premature cancer-related mortality in Europe. Int J Cancer, 136, 136-45.
14. Hanly P, Timmons A, Walsh PM, et al (2012). Breast and prostate cancer productivity costs: a comparison of the human capital approach and the friction cost approach. Value Health, 15, 429-36.
15. Hanly PA, Sharp L (2014). The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden. BMC Cancer, 14, 224.
16. Horm JW, Sondik EJ (1989). Person-years of life lost due to cancer in the United States, 1970 and 1984. Am J Public Health, 79, 1490-3.
17. Iran SCo (2013). Iran Statistical Yearbook, available from: http://www.amar.org.ir/Default.aspx?tabid=2153, accessed on:(10.09.2013) [Online].
18. Jemal A, Center MM, DeSantis C, et al (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907.
19. Jonsson B, Wilking N (2007). The burden and cost of cancer. Ann Oncol, 18, 8-22.
20. Kanavos P (2006). The rising burden of cancer in the developing world. Ann oncol, 17, 15-23.
21. Kim JL, Cho KH, Park EC, et al (2014). A single measure of cancer burden combining incidence with mortality rates for worldwide application. Asian Pac J Cancer Prev, 15, 433-9.
22. Lee WC (1997). Quantifying the future impact of disease on society: life table-based measures of potential life lost. Am J Public Health, 87, 1456-60.
23. Li C, Ekwueme DU (2010). Years of potential life lost caused by prostate cancer deaths in the United States-projection from 2004 through 2050. Cancer Epidemiol, 34, 368-72.
24. Ministry of Labour and Social Welfare, Iran (2013). Labour Market Information System. available from: Http://www.Amarkar.Ir/asp/statreport.Aspx. accessed on:(01/04/2013) [Online].
25. Naghavi M, Abolhassani F, Pourmalek F, et al (2009). The burden of disease and injury in Iran 2003. Population Health Metrics, 7, 9.
26. Pham TM, Fujino Y, Matsuda S, et al (2010). Premature mortality due to cancer in Japan, 1995 and 2005. Int J Cancer, 127, 190-4.
27. Rashidian H, Davoudi R, Ghiasvand R, et al (2013). Prevalence and Incidence of premenopausal and postmenopausal breast cancer in Iran in 2010. Basic Clinical Cancer Res, 5, 2-10.
28. Roya N, Abbas B (2013). Colorectal cancer trends in Kerman province, the largest province in Iran, with forecasting until 2016. Asian Pac J Cancer Prev, 14, 791-3.
29. Taghavi A, Fazeli Z, Vahedi M, et al (2012). Increased trend of breast cancer mortality in Iran. Asian Pac J Cancer Prev, 13, 367-70.
30. Tarricone R (2006). Cost-of-illness analysis: What room in health economics? Health Policy, 77, 51-63.
31. The central bank of Iran (CBI). 2014. exchange rate, available at: Http://www.Cbi.Ir/exrates/rates_fa.Aspx, accessed on: (20.09.2014) [Online].
32. World Bank (2014). World Development Indicators, Labor force participation rate, available at: http://data.worldbank.org/indicator/SL.TLF.CACT.ZS ,accessed on:(10.10.2014).
33. World Health Organization. 2014. Global Health Observatory Data Repository ; available from: http://apps.who.int/gho/data/?theme=mainandvid=60760, accessed on:(01/10/2014) [Online].
34. Yabroff KR, Bradley CJ, Mariotto AB, et al (2008). Estimates and projections of value of life lost from cancer deaths in the United States. J Natl Cancer Inst, 100, 1755-62.